乳腺癌OCT临床影像数据集

本数据集适用于医疗机构、企业用户及科研单位，可广泛应用于乳腺癌临床诊疗与科研创新工作，具体如下：
（1）医疗机构：提供高质量的乳腺癌OCT影像数据；辅助医生通过OCT影像特征分析，提供实时影像参考，优化术中决策；推动建立中国人群乳腺癌OCT影像诊断标准，促进OCT技术在临床的规范化应用。
（2）企业用户：AI医疗公司训练深度学习模型，实现乳腺癌病灶的自动分割与分类，开发OCT影像的3D可视化工具，增强诊断直观性，优化人机交互体验；医学影像设备厂商可根据数据集性能优化OCT探头的成像性能，为手术机器人导航系统提供光学引导基准，提高手术精准度。
（3）科研机构：用于乳腺癌OCT影像特征分析、组织光学研究、新型成像模式开发及医学教育培训，提升医师判读能力，助力医学人才培养。
解决的核心问题：通过OCT影像高分辨率特性，辅助医生识别微米级乳腺组织病变；为AI辅助诊断算法开发提供高质量训练数据；支持乳腺癌诊疗标准化研究。

This dataset is applicable to medical institutions, enterprise users and research units, and can be widely used in clinical diagnosis, treatment and scientific research innovation of breast cancer. The specific application scenarios are as follows:
1. For medical institutions: Provide high-quality OCT imaging data of breast cancer; assist doctors in providing real-time imaging references through OCT imaging feature analysis to optimize intraoperative decision-making; promote the establishment of breast cancer OCT imaging diagnostic standards for the Chinese population, and facilitate the standardized clinical application of OCT technology.
2. For enterprise users: AI medical companies can train deep learning models to realize automatic segmentation and classification of breast cancer lesions, develop 3D visualization tools for OCT images to enhance the intuitiveness of diagnosis and optimize human-computer interaction experience; medical imaging equipment manufacturers can optimize the imaging performance of OCT probes based on this dataset, provide optical guidance benchmarks for surgical robot navigation systems, and improve surgical accuracy.
3. For research institutions: It can be used for breast cancer OCT imaging feature analysis, tissue optics research, new imaging mode development and medical education and training, to improve doctors' image interpretation ability and help cultivate medical talents.

Core issues addressed: Assist doctors in identifying micron-scale breast tissue lesions by leveraging the high-resolution characteristics of OCT images; provide high-quality training data for the development of AI-assisted diagnosis algorithms; support standardized research on breast cancer diagnosis and treatment.